Analysis of urine biomarkers for early determination of acute kidney injury in non-septic and non-asphyxiated critically ill preterm neonates
dc.authorid | Elmas, Ahmet Taner/0000-0002-9749-6115; | |
dc.authorwosid | Tabel, Yilmaz/AAF-9801-2020 | |
dc.authorwosid | Elmas, Ahmet Taner/ABI-1338-2020 | |
dc.authorwosid | ELMAS, Ahmet Taner/W-4101-2017 | |
dc.contributor.author | Elmas, A. T. | |
dc.contributor.author | Karadag, A. | |
dc.contributor.author | Tabel, Y. | |
dc.contributor.author | Ozdemir, R. | |
dc.contributor.author | Otlu, G. | |
dc.date.accessioned | 2024-08-04T20:41:42Z | |
dc.date.available | 2024-08-04T20:41:42Z | |
dc.date.issued | 2017 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Objective: We designed the present study to test the hypothesis that urinary biomarkers might predict acute kidney injury (AKI) development in non-septic and non-asphyxiated critically ill preterm infants. We evaluated urine (u) sistatin-C (uCys-C), kidney injury molecule-1 (uKIM-1) and neutrophil gelatinase associate lipocaline (uNGAL) as markers of AKI. Methods: Sixty-four preterm infants with gestational age between 28 and 32 weeks were included in this study. Biomarkers were measured on day of life (DOL) 1, 3, and 7. Results: uNGAL levels in the AKI group were significantly higher than in no-AKI group on DOL 1, 3 and 7 (p = 0.016, p = 0.007 and p = 0.0014, respectively). Conclusions: uNGAL is sensitive, early, and noninvasive AKI biomarkers, increasing significantly in non-septic and non-asphyxiated critically ill preterm neonates. | en_US |
dc.identifier.doi | 10.3109/14767058.2016.1171311 | |
dc.identifier.endpage | 308 | en_US |
dc.identifier.issn | 1476-7058 | |
dc.identifier.issn | 1476-4954 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 27020372 | en_US |
dc.identifier.scopus | 2-s2.0-84964489965 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 302 | en_US |
dc.identifier.uri | https://doi.org/10.3109/14767058.2016.1171311 | |
dc.identifier.uri | https://hdl.handle.net/11616/97292 | |
dc.identifier.volume | 30 | en_US |
dc.identifier.wos | WOS:000389664200011 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Journal of Maternal-Fetal & Neonatal Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Acute kidney injury | en_US |
dc.subject | kidney injury molecule-1 | en_US |
dc.subject | neutrophil gelatinase associate lipocaline | en_US |
dc.subject | preterm infants | en_US |
dc.subject | sistatin-C | en_US |
dc.subject | urine | en_US |
dc.title | Analysis of urine biomarkers for early determination of acute kidney injury in non-septic and non-asphyxiated critically ill preterm neonates | en_US |
dc.type | Article | en_US |